Insights |

By Topic

Clear All

Dividend Stocks

Growth Stocks

Blue Chip Stocks

Market Trends

Economic Updates

Interest Rates & Inflation

Global Markets

Small Caps & Emerging Stocks

Retirement & Superannuation

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

ASX 200 Today

CSL's Leadership Shock: What CEO Exits Mean for ASX Healthcare

CSL Limited (ASX: CSL), Australia's largest healthcare company, dropped a bombshell on investors this week. On 10 February, the company announced that CEO Dr Paul McKenzie was leaving, effective immediately. Shares crashed around 5% in the closing auction, finishing at A$171.39. The very next morning, weak half-year earnings sent shares plunging again, falling as low as A$151.30 before recovering to around A$163.44, an eight-year low.

ASX 200 Today

CSL

Energy

Uranium's AI Power Trade Under Pressure: What It Means for ASX Miners

It has been a wild ride for uranium investors in 2026. Just weeks ago, uranium futures hit US$100 per pound, the highest price since February 2024. The reason? A growing belief that the AI boom would need nuclear power to keep the lights on in massive data centres. Money poured into the sector.

Energy

ASX 200

Growth Stocks

Evolution Mining Up Over 150%: What Analyst Price Targets Reveal About Gold Mining Shares on the ASX

Evolution Mining shares have surged more than 150%, yet analyst price targets still sit below current levels. This article explains why targets lag strong gold prices, what EVN’s fundamentals reveal, and how investors should interpret the growing gap between analyst models and market reality.

Growth Stocks

mining

Healthcare

Is Mesoblast a Buy After Its A$186M Refinancing? Here's What Investors Need to Know

Mesoblast has secured a A$186 million non-dilutive refinancing and is delivering strong Ryoncil revenue growth. This article breaks down what the deal means for cash flow, risk, and long-term upside, helping investors assess whether MSB is turning into a genuine commercial biotech opportunity.

Healthcare

ASX 200

Dividend Stocks

ASX Dividend Yields at Multi-Year Lows: 6 Income Stocks to Watch

ASX yields are at multi-year lows. Review six income stocks with stronger yield support and learn how franking can change the real return.

Dividend Stocks

Dividend Shares

ASX 200 Today

Pilbara Minerals vs IGO vs Liontown: Macquarie Names Top Lithium Stocks to Buy and Avoid

Stay ahead of the lithium market recovery. Macquarie reveals which ASX producers are positioned to benefit from the sector rebound—and which stocks investors should avoid as volatility continues.

ASX 200 Today

ASX 200

Insights |

By Topic

CSL's Leadership Shock: What CEO Exits Mean for ASX Healthcare

Uranium's AI Power Trade Under Pressure: What It Means for ASX Miners

Evolution Mining Up Over 150%: What Analyst Price Targets Reveal About Gold Mining Shares on the ASX

Is Mesoblast a Buy After Its A$186M Refinancing? Here's What Investors Need to Know

ASX Dividend Yields at Multi-Year Lows: 6 Income Stocks to Watch

Pilbara Minerals vs IGO vs Liontown: Macquarie Names Top Lithium Stocks to Buy and Avoid

Our friendly team is here to help.

ASR

Insights

Education

Documents